Increasing Incidence of Hematologic Diseases to Drive Global Apheresis Equipment Market Growth

The apheresis equipment market was valued at US$ 1,985.83 million in 2018 and it is projected to reach US$ 3,528.44 million in 2027; it is expected to grow at a CAGR of 6.9% from 2019 to 2027.

Apheresis is a process in which blood is temporarily removed from the donor’s body and separated into various components such as plasma, platelets, red blood cells as well as white blood cells, by centrifugation or membrane separation process. The impurities and abnormal components in the blood are removed by the process of apheresis; hence, it is preferred for curing or controlling diseases. The apheresis equipment separates blood components using centrifugation or membrane separation, depending on the components to be separated. The growth of the global apheresis equipment market is attributed to the rising number of voluntary blood donors, increasing incidence of hematologic diseases and increasing elderly population. However, high cost of apheresis equipment and complications associated with apheresis are the major factor hindering the market growth.

Request for sample at: https://www.theinsightpartners.com/sample/TIPHE100001288/

Key Findings from The apheresis equipment Market

  • In terms of product, the global apheresis equipment market is segmented into disposable apheresis kits and apheresis machine. In 2018, the disposable apheresis kits segment held largest share of the market. Also, the same segment is estimated to register the highest CAGR during the forecast period.
  • Based on technology, the global apheresis equipment market is segmented into centrifugation and membrane separation. The membrane separation segment held the largest market share in 2018. Also, the same segment is estimated to grow at the highest CAGR during the forecast period.
  • Based on procedure, the global apheresis equipment market is segmented into plasmapheresis, photopheresis, erythrocytapheresis, leukapheresis, plateletpheresis, and LDL-apheresis. The plasmapheresis segment held the largest market share in 2018. However, the LDL-apheresis segment is estimated to grow at the highest CAGR during the forecast period.
  • In terms of therapeutic area, the global apheresis equipment market is segmented into hematology, renal diseases, neurology, and other therapeutic areas. In 2018, the hematology segment held largest share of the market. Moreover, the same segment is expected to grow at the fastest rate during the forecast period.
  • In terms of end user, the global apheresis equipment market is segmented into blood banks/ blood donation centers, hospitals & clinics and ambulatory surgical centers. The hospitals & clinics segment held the largest share of the market in 2018. Also, the same segment is estimated to grow at the highest CAGR during the forecast period.
  • The major players operating in the apheresis equipment market include, Medica SPA, Terumo Corporation, B. Braun Melsungen AG, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, Haemonetics Corporation, HemaCare Corporation, Kaneka Medix Corporation, Kawasumi Laboratories, Inc., and Medicap Clinic GmbH. In the apheresis equipment market the companies has carried out various organic growth strategies that have enabled the companies to strengthen their product offering in the market.

Increasing Incidence of Hematologic Diseases to Drive Global Apheresis Equipment Market Growth

Blood diseases affects one or more parts of the body as well as total health. There are various blood diseases caused by certain genes. Some of the common blood diseases include anemia, hemophilia, von Willebrand disease (VWD), blood cancers such as myeloma, leukemia lymphoma and others. The rising number of these diseases demands need for blood transfusion which is expected to increase the requirement of apheresis equipment thereby bolstering the growth of the market.

Anemia is the known to be the common blood disorder, and according to the National Heart, Lung, and Blood Institute, it affects more than 3 million Americans. Moreover, according to the World Health Organization (WHO), anemia affects approximately 1.62 billion people worldwide. Furthermore, according to the Centers of Disease Control and Prevention (CDC), hemophilia A affects approximately 1 in 5,000 male births.

Two of the most common types of apheresis used for the removal of harmful substance from blood are cytapheresis and plasma exchange. Plasma exchange is used to treat disorders such as myasthenia gravis, thrombotic thrombocytopenic purpura, multiple sclerosis and others. Cytapheresis is a process that removes excess number of blood cells and are used in treatment of leukemia, polycythemia and thrombocythemia. The rising incidence of hematologic diseases is thus expected to foster the growth of global apheresis equipment market over the coming years.

Place an Order Now: https://www.theinsightpartners.com/buy/TIPHE100001288/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.

Contact Us

Contact Person: Sameer Joshi

Phone: +1-646-491-9876

Email- sales@theinsightpartners

Back to news